Refractory Anaphylaxis: Definition and Management
Refractory anaphylaxis is defined as persistent anaphylactic symptoms despite adequate initial treatment with epinephrine and fluids, requiring additional management strategies beyond standard protocols. 1, 2
Definition and Characteristics
- Refractory anaphylaxis indicates insufficient response to standard treatment, typically identified after 10 minutes of sustained inadequate response despite appropriate epinephrine dosing and fluid resuscitation 1
- It can result from the pathological process alone or be compounded by underlying medical conditions, surgical factors, or anesthesia 1
- Refractory anaphylaxis represents a severe end of the anaphylaxis spectrum that requires escalated interventions beyond initial epinephrine treatment 2
- While standard anaphylaxis typically responds to intramuscular epinephrine, refractory cases persist despite this intervention 3
Epidemiology and Risk Factors
- In a study of 145 patients with ICM (iodinated contrast media) anaphylaxis, 4.1% developed refractory anaphylaxis 4
- Risk factors for developing refractory anaphylaxis include:
Clinical Presentation
- Persistent life-threatening hypotension despite adequate epinephrine and fluid administration 1
- Ongoing severe bronchospasm unresponsive to initial treatments 1
- Cardiovascular collapse requiring advanced interventions 1
- Symptoms that continue or worsen despite standard anaphylaxis management 2
Management Protocol for Refractory Anaphylaxis
Initial Recognition and Assessment
- Re-evaluate after 10 minutes of standard anaphylaxis treatment if symptoms persist 1
- Confirm adequate dosing of epinephrine and volume resuscitation 1
- Assess for complicating factors (e.g., beta-blocker use, underlying cardiac disease) 6
Escalated Epinephrine Administration
- Double the initial bolus dose of epinephrine 1
- Start an epinephrine infusion after a total of three bolus doses 1
- Consider intravenous epinephrine administration in severe cases under appropriate monitoring 3, 7
Advanced Cardiovascular Support
- Ensure adequate volume replacement with crystalloids or colloids 1, 8
- Consider alternative vasopressors such as vasopressin, norepinephrine, metaraminol, or phenylephrine 1
- For patients taking beta-adrenergic receptor blockers, administer IV glucagon 1-2 mg 1
- Consider extracorporeal life support in facilities where skills and equipment are available 1
Respiratory Management
- Add inhaled bronchodilators for persistent bronchospasm 1
- Consider adding intravenous bronchodilators if respiratory symptoms persist 1
- Secure the airway early if there are signs of upper airway compromise 7
Additional Interventions
- Corticosteroids may be given after adequate resuscitation, though they have no immediate role in acute management 1
- Antihistamines can be administered after adequate resuscitation but are not a priority 1
- Position the patient supine or in Trendelenburg position to improve venous return 4
- Provide supplemental oxygen 4
Post-Crisis Management
- Extended observation period (minimum 6 hours) is recommended for patients who experienced refractory anaphylaxis 4
- Hospital admission should be considered for patients with severe or refractory reactions 9
- Obtain serum tryptase samples at 1 hour and 2-4 hours after reaction onset, with a baseline sample at least 24 hours post-reaction 1
- All patients should receive education on anaphylaxis management and be referred to an allergist 5
Important Distinctions and Considerations
- Refractory anaphylaxis differs from biphasic anaphylaxis, which occurs when symptoms resolve completely but then recur up to 72 hours later (mean 11 hours) 4
- Sugammadex has no immediate role in the resuscitation of suspected anaphylaxis 1
- The absence of cutaneous symptoms does not rule out anaphylaxis, particularly in rapidly progressive cases 10
- Bradycardia can occasionally occur in anaphylaxis due to the Bezold-Jarisch reflex, despite tachycardia being more common 8, 10
Understanding and promptly recognizing refractory anaphylaxis is crucial for implementing appropriate escalated interventions to prevent morbidity and mortality in these severe cases.